This agreement marks a milestone for Baidu to use its strengths in computational biology to optimize mRNA vaccine and therapy designs
State-of-the-art R&D facility designed to foster collaboration across world-class science ecosystem
Dicerna develops RNAi-based therapies to selectively silence genes that cause or contribute to disease
Bioanalytical approach to accelerate development efforts in the identification of compounds that can treat chlorine or sulfur mustard injuries
The collaboration aims to deliver greater insights to the oncology fraternity, predict patient therapy responses and enable therapy selection resulting in optimal treatment outcomes.
Strengthens supply chain continuity with first manufacturing facility outside of the U.S.
Ipsen obtains an exclusive license to develop, manufacture and commercialize a pre-clinical stage METTL3-inhibitor programme
First anticipated spinout from the alliance, Circle Therapeutics, to develop novel muscle stem cell therapies for a variety of skeletal muscle disorders
Standalone use of Sputnik Light also provides much higher efficacy against severe disease and hospitalizations
The company has enabled a transformation across three core areas with an investment target of US $ 150 million
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
